LumiThera_FDA
November 5, 2024

FDA Approves Lumithera’s Photobiomodulation Device for Dry AMD

Lumithera’s Valeda becomes the first FDA-approved treatment for vision loss caused by dry AMD Dry AMD sufferers in the United…

Discover our fascinating content at issuu

explore